Roku's Growth Surges: Analysts Raise Price Targets As Company Expands Ad Reach - Roku ( NASDAQ:ROKU )
Roku beats Q4 expectations with a smaller loss and higher-than-expected revenue, raising analysts' confidence in the stock. Analysts raise Roku's price forecasts, citing strong ad growth, expanding platform, and improved EBITDA guidance for FY25.
Why Recursion Pharmaceuticals Stock Is Soaring Today
Shares of Recursion Pharmaceuticals ( NASDAQ: RXRX ) had soared by 15.8% as of 12:06 p.m. ET on Friday. Did the clinical-stage biotech company report great news? Nope. Instead, the stock's gains appeared to be driven by moves made by Nvidia ( NASDAQ: NVDA ) .The giant chipmaker disclosed its own ...
West Pharmaceutical Servs's Options Frenzy: What You Need to Know - West Pharmaceutical Servs ( NYSE:WST )
Investors with a lot of money to spend have taken a bullish stance on West Pharmaceutical Servs WST. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Market Whales and Their Recent Bets on Citigroup Options - Citigroup ( NYSE:C )
Financial giants have made a conspicuous bullish move on Citigroup. Our analysis of options history for Citigroup C revealed 42 unusual trades. Delving into the details, we found 45% of traders were bullish, while 45% showed bearish tendencies.
Smart Money Is Betting Big In UPS Options - United Parcel Service ( NYSE:UPS )
Investors with a lot of money to spend have taken a bullish stance on United Parcel Service UPS. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Transaction in Own Shares
Shell plc ( the 'Company' ) announces that on 14 February 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:
Analyst Cuts Regeneron Pharmaceuticals ( REGN ) Price Target After Sales Concerns and Investor Lawsuit- Hagens Berman - Regeneron Pharmaceuticals ( NASDAQ:REGN )
SAN FRANCISCO, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing legal challenges, analysts TD Cowen recently lowered its price target for Regeneron to $1,030 from ...
El Salvador's Bitcoin President Nayib Bukele Meets Michael Saylor To 'Accelerate Adoption'
El Salvador is adjusting its Bitcoin policies to comply with a $1.4 billion IMF loan, limiting Bitcoin's use for tax payments. MicroStrategy continues expanding its Bitcoin reserves, recently adding 7,633 BTC and bringing its total holdings to 478,740 BTC.
Why Twilio Stock Just Crashed 16.5%
Twilio ( NYSE: TWLO ) stock tumbled 16.5% through 10:55 a.m. ET Friday after a mixed earnings report last night.Heading into Q4 2024, analysts forecast Twilio would earn $1.03 per share, adjusted for one-time items, on sales of $1.18 billion.






